Abstract
As the average age of the population increases, so will the prevalence of chronic respiratory diseases and associated multimorbidity. This will result in a more complex clinical environment. Part of the solution will be to allow patients to be co-creators in the design of their care. It will also require clinicians to shift in their current approaches to care, step out of the disease- or pathology-oriented approach and embrace new ideas. In an effort to prepare the respiratory community for the challenge, we reflect on concepts to empower patients via multidisciplinary systems, new technologies and transition from end-of-life care to advanced care planning.
Abstract
Increasing life expectancy will lead to the need for better respiratory and multimorbid care http://bit.ly/2KgLvGu
Footnotes
Conflict of interest: M. Gaga has received departmental grants and honoraria from AZ, GSK, Menarini, Chiesi, Novartis, BMS, MSD, Roche, Elpen and Pharmaten outside of this work.
Conflict of interest: P. Powell is an employee of the European Lung Foundation.
Conflict of interest: M. Almagro reports nonfinancial support from Polyphor outside the submitted work.
Conflict of interest: I. Tsiligianni reports personal fees from Novartis, grants and personal fees from GSK, and personal fees and other support from Boehringer Ingelheim, outside the submitted work.
Conflict of interest: Dr. Loukides has nothing to disclose.
Conflict of interest: Dr. Roca has nothing to disclose.
Conflict of interest: M. Cullen has nothing to disclose.
Conflict of interest: A.K. Simonds has nothing to disclose.
Conflict of interest: B. Ward is an employee of the European Respiratory Society.
Conflict of interest: I. Saraiva has nothing to disclose.
Conflict of interest: T. Troosters has nothing to disclose.
Conflict of interest: C. Robalo Cordeiro has nothing to disclose.
- Received May 21, 2019.
- Accepted July 29, 2019.
- Copyright ©ERS 2019
This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.